2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide

B-Raf proto-oncogene, serine/threonine kinase ; Homo sapiens







3 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 23658559 Comparison of responses of human melanoma cell lines to MEK and BRAF inhibitors. 2013 1
2 19018267 KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer. 2008 Dec 16 1
3 17911174 Inhibitory effects of the mitogen-activated protein kinase kinase inhibitor CI-1040 on the proliferation and tumor growth of thyroid cancer cells with BRAF or RAS mutations. 2007 Dec 2